Details for 2018185298
Up to date per 16.04.2026
Actions
Details for 2018185298
Granted/Registered
European Patent
27.03.2019 A
27.10.2021 B1
06.01.2010
US
29261410 P
A61K 39/395 20060101AFI20181211BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, OsakaJP
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
SEXTON, Daniel J.Dyax Corp. 59 Marvin Road Melrose, MA 02176US
VISWANATHAN, Malini12 Farmstead Way Acton, MA 01720US
Information about Fees